Navigation Links
Global HIV Infection Drug Pipeline Analysis
Date:12/13/2013

MUMBAI, December 13, 2013 /PRNewswire/ --

Bharat Book Bureau presents Global HIV Infection Drug Pipeline Analysis. This report provides the discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retroviral in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been successful in improving the quality of life for HIV patients and prevented the virus from developing into AIDS. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.6 in 2012, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years.

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935)

Bharat Book Bureau presents the report entitled "Global HIV Infection Drug Pipeline Analysis" (http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html ) It gives comprehensive insight on the various drugs being developed for the treatment of HIV Infection. Research report covers all the ongoing drugs being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process.

Following parameters for each drug profile in clinical development phase are covered in "Global HIV Infection Drug Pipeline Analysis" research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Orphan Designation by Indication, Country & Organization
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

HIV Infection Drug Development by Clinical Phase:

  • Research: 31
  • Preclinical: 140
  • Phase-I: 53
  • Phase-I/II: 18
  • Phase-II: 39
  • Phase-III: 7
  • Preregistration: 2
  • Registered: 2
  • Marketed: 34

Table of Contents

  • HIV Infection Drug Market Overview
  • HIV Infection Drug Clinical Development Phase: Research
  • Overview
  • HIV Infection Drug Profiles in Clinical Phases
  • HIV Infection Drug Clinical Development Phase: Preclinical
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I/II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-III
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Preregistration
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Registered
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • Marketed Drugs
  • Overview
  • Marketed Drug Profile

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=430480

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: poonam@bharatbook.com
W: http://www.bharatbook.com

 


'/>"/>
SOURCE Bharat Book Bureau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Equine Healthcare Market is Expected to Reach USD 24.5 Billion Globally in 2019: Transparency Market Research
2. CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
3. Global Radiation Detection, Monitoring & Safety Market Report 2013-2017
4. Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
5. Wearable Medical Devices Market is Expected to Reach USD 5.8 Billion Globally in 2019: Transparency Market Research
6. Global Laparoscopic Devices Industry
7. Global Gelatin Industry
8. Global Carotenoids Industry
9. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
10. Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research
11. EEG/EMG/Brain Function Monitoring - Global Strategic Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... SALT LAKE CITY, UTAH (PRWEB) , ... April ... ... Josée Côté as Account Manager for the North East region. Côté has 20+ ... operations and consulting. Prior to Phytomer, Côté worked with an array of high-end ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Neb. (PRWEB) , ... April 27, 2017 , ... ... was named the 2017 North American CAREGiverSM of the Year for her extraordinary ... selects one of its 60,000 North American professional caregivers for the prestigious award ...
(Date:4/27/2017)... GA (PRWEB) , ... April 27, 2017 , ... Are ... a tragic spike in water-related accidents and drownings during the summer. While most of ... is that these situations occur every day. Very few people are taking the time ...
Breaking Medicine News(10 mins):